NAM Clinical Symposium 2008
Optimising HIV Treatment and Care, Evolving Treatment Paradigms
Listen to the symposium here
Striking advances in HIV medicine, including improved efficacy and tolerability profiles of antiretroviral agents as well as the introduction of new classes of drugs, have profound implications for the clinical management of primary, chronic and treatment experienced patients. These benefits have resulted in patients living longer with HIV, requiring physicians to manage co-morbidities associated with ageing as well as those related to HIV diseases. The policy context within which these advances have developed has included routine testing for HIV, enabling earlier diagnosis and potential for treatment intervention, restrictions on access as determined by immigration status and the increasing criminalisation of HIV transmission.
On Thursday 29 May, 170 clinicians, nurses, scientific experts, policy officials, NHS commissioners, HIV voluntary sector staff and treatment advocates attended NAM's 2008 clinical symposium, held at the Royal College of Physicians in London. The event was intended to promote clinical skills building and advocacy using a combination of expert lectures, clinical case presentations and interactive discussions. You can listen to the day’s presentations and discussions, by clicking on the links below.
- When to start treatment: Where is the pendulum?
Dr Martin Fisher, Royal Sussex County Hospital, Brighton, UK.
- The changing patient profile: Living longer with HIV.
Dr Mark Nelson, Chelsea and Westminster Hospital, London, UK.
- Questions & Answers
- Advances in treatment: New agents, classes, novel stategies.
Professor Joep Lange, Academic Medical Centre, University of Amsterdam, Netherlands.
- Moderated discussion
Developments in HIV drug resistance and diagnostic technology.
- Developments in HIV drug resistance and diagnostic technology.
Professor Deenan Pillay, University College, London, UK.
- Managemant of psychiatric disorders in people with HIV.
Dr José Catalan, Chelsea and Westminster Hospital, London, UK..
- Case Studies.
Case studies and the results of audience voting.
The future of HIV policy and practice.
- What will HIV clinical practice look like in the future?
Seema Yasmin, Cambridge University School of Clinical Medicine, UK.
- How can HIV policy optimise HIV treatment and care?
Yusef Azad, National AIDS Trust.
- Moderated discussion.
The symposium was convened by Keith Alcorn, Senior Editor, NAM and Yasmin Halima, editorial consultant to NAM and Consultant, Bill & Melinda Gates Foundation. NAM’s 2008 clinical symposium was supported by unrestricted education grants from Abbott Laboratories Ltd, Bristol-Myers Squibb, Gilead Sciences Ltd, Merck Sharp & Dohme Ltd, Pfizer Ltd and Tibotec, a division of Janssen Cilag Ltd.